Nannan Kang
4PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 09, 2024
A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignancies.Chen Zhao, Yuan Zeng, Nannan Kang
|Mar 28, 2024
Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA-24 with Tumor-Selective Toxicity.Nannan Kang, Jun Ma, Yuling Hu
|Sep 16, 2023
Novel specific anti-ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis.Nannan Kang, Buxi Fan, Yao Sun
|Nov 26, 2022
Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance.Nannan Kang, Xue Liang, Buxi Fan
Pageof 1
